MacroLensNP नेपालीने Sign in Create accountSign up
Free · Life Insurance

SNLI Sun Nepal Life Insurance Company Limited

Rs 416.00 +2.20 (+0.53%) as of 2026-11-06 15:00:00
Open
411.00
High
417.00
Low
411.00
Prev. close
413.80
Volume
6,847
Turnover
28.48 lakh
Avg volume (30 d)
19,412
52-week low Rs 375.00
high Rs 528.30 -21.3% from the 52-week high

Sun Nepal Life Insurance Company Limited (SNLI) is listed on the Nepal Stock Exchange in the Life Insurance sector. Its share price is Rs 416.00 as of 6 November 2026, 21.3% below its 52-week high of Rs 528.30 and 10.9% above its 52-week low of Rs 375.00. It trades at a P/E of 52.5 on earnings per share of Rs 7.92, close to the Life Insurance sector's median P/E of 56.6.

SNLI paid a dividend in 2 of the last 3 fiscal years we track; the latest was 15.26% cash and 5.00% bonus for FY 2081/2082. Promoters hold 70% of the shares and the public 30%.

Key figures latest report 2082/2083 Q4

Market value
2,198 crore · 21.98 arba
Shares listed
52,827,936
Paid-up capital
528.28 crore · 5.28 arba
EPS (annualised)
Rs 7.92
P/E
52.5
Book value / share
Rs 142.88
P/B
2.91
ROE
5.6%
ROA
2.00%
Dividend yield
3.67%
Net profit (annualised)
41.86 crore
Reserves
–
Total assets
2,091 crore · 20.91 arba
Debt to equity
1.77

Quarter by quarter trailing 12 months at each quarter

QuarterEPSEPS growth (y/y)Net profitRevenueROE
2082/2083 Q4 7.92 -22.8% 41.86 crore 473.72 crore · 4.74 arba 5.5%
2082/2083 Q3 10.48 +34.9% 55.35 crore 352.42 crore · 3.52 arba 7.2%
2082/2083 Q2 10.33 +3.2% 54.56 crore 318.21 crore · 3.18 arba 7.3%
2082/2083 Q1 11.65 +6.9% 61.56 crore 244.12 crore · 2.44 arba 8.2%
2081/2082 Q4 10.27 -5.7% 54.25 crore 337.76 crore · 3.38 arba 7.6%
2081/2082 Q3 7.77 -37.6% 41.03 crore 371.31 crore · 3.71 arba 6.1%
2081/2082 Q2 10.01 -19.5% 52.88 crore 355.31 crore · 3.55 arba 8.0%
2081/2082 Q1 10.90 -12.9% 57.58 crore 326.76 crore · 3.27 arba 8.9%

Dividends

Fiscal yearBonusCashBook close
2081/20825.00% 15.26% 29 Dec 2025
2080/2081– – –
2079/208023.80% 1.25% 9 May 2024

Bonus / right shares: Dec 2025 Bonus share 5% · Apr 2025 Right share 1:0.27 at Rs 100 · May 2024 Bonus share 23.8%

Who owns it

Promoters 70% Public 30%
Public float
15,848,363 shares
Mutual funds hold
4.3% of the float
Promoter lock-in
–

Latest news

MacroLens analysis of SNLI

More on SNLI on the full desk The rating and verdict, fair value, dump risk and warning signs, the 12-month target, the buy / sell meter with every past signal, cornering and broker activity - the analysis behind every number above. Create an account - 7-day trial

Other Life Insurance companies

CompanyPriceTodayP/EP/BMarket value
NLIC Nepal Life Insurance Co. Ltd. 740.00 +0.14% 150.75.87 7,015 crore · 70.15 arba
LICN Life Insurance Co. Nepal 799.00 +0.26% 108.34.49 4,395 crore · 43.95 arba
NLICL National Life Insurance Co. Lt... 580.00 -0.17% 89.14.54 3,301 crore · 33.01 arba
HLI Himalayan Life Insurance Limit... 303.00 -0.10% 87.13.25 2,770 crore · 27.70 arba
RNLI Reliable Nepal Life Insurance... 446.00 -0.67% 39.83.00 2,318 crore · 23.18 arba
PMLI Prabhu Mahalaxmi Life Insuranc... 429.00 +0.37% 60.63.68 2,277 crore · 22.77 arba
ALICL Asian Life Insurance Co. Limit... 422.20 -0.42% 53.53.51 2,217 crore · 22.17 arba
ILI IME Life Insurance Company Lim... 443.00 +0.07% 37.93.27 2,215 crore · 22.15 arba

Every Life Insurance company 14

Browse all NEPSE stocks by sector →

SNLI: common questions

What is the share price of SNLI today?

SNLI (Sun Nepal Life Insurance Company Limited) closed at Rs 416.00 as of 6 November 2026 on NEPSE.

Does SNLI pay dividends?

SNLI paid a dividend in 2 of the last 3 fiscal years we track; the latest was 15.26% cash and 5.00% bonus for FY 2081/2082.

What is the P/E ratio of SNLI?

It trades at a P/E of 52.5 on earnings per share of Rs 7.92, close to the Life Insurance sector's median P/E of 56.6.

Is SNLI a good buy?

This page is not buy or sell advice. MacroLens NP rates every NEPSE company on its fundamentals - SNLI's rating, fair value, dump risk and broker activity are on the desk, free for 7 days.

Prices from NEPSE; figures from the company's quarterly reports; dividends, ownership and news from public filings. Research, not a recommendation to buy or sell - see the risk disclosure.